UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of October 2018
333-206723
(Commission File Number)
P.V. Nano Cell Ltd.
(Exact name of Registrant as specified in its charter)
8
Hamasger Street
Migdal Ha’Emek, Israel 2310102
(Address of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____
2018 Special Meeting of Shareholders
Attached hereto as Exhibits 99.1 and 99.2 are a copy of the Company’s proxy statement and form of proxy for 2018 special annual meeting of shareholders, which is being distributed to shareholders on or about October 23, 2018.
1
Exhibit Index
Exhibit No. |
Description | |
99.1 |
Notice of Special General Meeting and Proxy Statement Oct 23 2018 | |
99.2 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
P.V. Nano Cell Ltd. | ||
Date October 30h, 2018 | By: | |
Name:
Dr. Fernando de la Vega Title: Chief Executive Officer |
3